Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xilio Therapeutics
Xilio Therapeutics
AbbVie signs heavily backloaded $2.1B Xilio biobucks pact in Big Pharma's latest T-cell engager deal
Fierce Biotech
Wed, 02/12/25 - 10:05 am
AbbVie
Xilio Therapeutics
T-cell engager
Gilead bets on Xilio cancer drug as biotech restructures
BioPharma Dive
Thu, 03/28/24 - 11:54 am
Gilead Sciences
Xilio Therapeutics
cancer
immunotherapy
restructuring
XTX301
solid tumors
Xilio reports preliminary data from Phase I solid tumors therapy trial
Clinical Trials Arena
Tue, 05/30/23 - 09:40 am
Xilio Therapeutics
clinical trials
solid tumors
XTX101
Biotechs put assets up for sale and on the shelf in quarterly pipeline clear-outs
Fierce Biotech
Wed, 11/9/22 - 10:53 am
Xilio Therapeutics
Protagonist Therapeutics
Arbutus BioPharma
Aptinyx
Xilio Therapeutics goes public as biopharma IPOs rumble forward in Q4
Endpoints
Fri, 10/22/21 - 12:02 pm
Xilio Therapeutics
IPOs
solid tumors
Xilio inks Merck deal to run checkpoint inhibitor combo trial
Fierce Biotech
Tue, 05/25/21 - 11:15 am
Xilio Therapeutics
Merck
Keytruda
XTX101
clinical trials
solid tumors
Xilio raises $95M to take twists on Yervoy and IL-2 into clinic
Fierce Biotech
Wed, 02/24/21 - 10:57 am
Xilio Therapeutics
funding
immunotherapy
clinical trials
cancer
oncology
Yervoy